Dividend Assets Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,536
| Closed | -$36K | – | 343 |
|
|
2023
Q4 | $36K | Sell |
2,536
-670
| -21% | -$9.51K | 0.01% | 279 |
|
|
2023
Q3 | $50K | Sell |
3,206
-8,600
| -73% | -$134K | 0.01% | 262 |
|
|
2023
Q2 | $185K | Sell |
11,806
-923
| -7% | -$14.5K | 0.04% | 170 |
|
|
2023
Q1 | $199K | Hold |
12,729
| – | – | 0.04% | 162 |
|
|
2022
Q4 | $199K | Sell |
12,729
-1,257
| -9% | -$19.7K | 0.04% | 162 |
|
|
2022
Q3 | $181K | Hold |
13,986
| – | – | 0.04% | 166 |
|
|
2022
Q2 | $196K | Sell |
13,986
-125
| -0.9% | -$1.75K | 0.04% | 173 |
|
|
2022
Q1 | $202K | Hold |
14,111
| – | – | 0.04% | 180 |
|
|
2021
Q4 | $192K | Hold |
14,111
| – | – | 0.04% | 187 |
|
|
2021
Q3 | $231K | Sell |
14,111
-503
| -3% | -$8.23K | 0.05% | 174 |
|
|
2021
Q2 | $246K | Buy |
14,614
+8,600
| +143% | +$145K | 0.05% | 171 |
|
|
2021
Q1 | $110K | Sell |
6,014
-168
| -3% | -$3.07K | 0.02% | 221 |
|
|
2020
Q4 | $113K | Buy |
+6,182
| New | +$113K | 0.02% | 212 |
|
|
2020
Q2 | – | Sell |
-25,062
| Closed | -$380K | – | 193 |
|
|
2020
Q1 | $380K | Sell |
25,062
-9,432
| -27% | -$143K | 0.09% | 116 |
|
|
2019
Q4 | $681K | Sell |
34,494
-17,777
| -34% | -$351K | 0.11% | 113 |
|
|
2019
Q3 | $899K | Sell |
52,271
-17,322
| -25% | -$298K | 0.14% | 97 |
|
|
2019
Q2 | $1.23M | Sell |
69,593
-21,730
| -24% | -$385K | 0.2% | 94 |
|
|
2019
Q1 | $1.86M | Buy |
+91,323
| New | +$1.86M | 0.3% | 76 |
|